Patent ID: 9623029
Date: 2017-04-18
CPC Classifications: A61K,A61P,C07D

Claim:
1. A method of treating a skin disorder selected from a bullous skin disorder, atopic dermatitis, skin sensitization, skin rash, contact dermatitis, and allergic contact sensitization, in a patient comprising administering to said patient a therapeutically effective amount of a compound selected from 3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]octanenitrile; and 3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]heptanenitrile; or a pharmaceutically acceptable salt thereof.